Management of the difficult nephrotic patient

Area of Science:

• Pediatric Nephrology
• Glomerular Diseases

Background:

• Nephrotic syndrome is common in children, often managed with steroids.
• Some children develop steroid resistance and toxicity, necessitating alternative treatments.
• Focal segmental glomerulosclerosis (FSGS) is a frequent biopsy finding in steroid-resistant nephrotic syndrome.

Purpose of the Study:

• To review management strategies for children with nephrotic syndrome.
• To identify effective treatments for steroid-resistant nephrotic syndrome, particularly FSGS.
• To explore options for patients with significant steroid toxicity.

Main Methods:

• Review of clinical management protocols for nephrotic syndrome.
• Analysis of treatment outcomes for steroid-resistant cases.
• Evaluation of therapeutic agents including alkylating agents, cyclosporine, and pulse methylprednisolone.

Main Results:

• Many children with nephrotic syndrome achieve remission with standard steroid therapy.
• Steroid-resistant nephrotic syndrome, often linked to FSGS, poses a challenge.
• Alternative treatments like oral alkylating agents or cyclosporine can manage some steroid-dependent cases.
• Pulse intravenous methylprednisolone and oral alkylating agents may improve outcomes in steroid-resistant FSGS.

Conclusions:

• While most children with nephrotic syndrome respond to steroids, a subset requires alternative therapies.
• Cyclosporine and specific combination therapies show promise for managing steroid-resistant nephrotic syndrome and FSGS.
• Effective management of steroid resistance is crucial to prevent progression to chronic kidney disease.